Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 819360, 11 pages
http://dx.doi.org/10.1155/2014/819360
Review Article

Multiparametric MRI-Targeted TRUS Prostate Biopsies Using Visual Registration

1Department of Radiology, Lille University Hospital, Lille University, 59000 Lille, France
2Inserm U703, 59120 Loos, France
3Department of Urology, Lille University Hospital, Lille University, 59000 Lille, France

Received 17 May 2014; Accepted 16 September 2014; Published 1 December 2014

Academic Editor: Barıs Turkbey

Copyright © 2014 Philippe Puech et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Loeb, A. Vellekoop, H. U. Ahmed et al., “Systematic review of complications of prostate biopsy,” European Urology, vol. 64, no. 6, pp. 876–892, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Valeri, B. Malavaud, O. Desrichard et al., “Strategies for early diagnosis and prevention of prostate cancer,” Bulletin du Cancer, vol. 97, no. 12, pp. 1499–1515, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Djavan, V. Ravery, A. Zlotta et al., “Prospective evaluation of prostate cancer detected on 1, 2, 3 and 4: when should we stop?” The Journal of Urology, vol. 166, no. 5, pp. 1679–1683, 2001. View at Google Scholar
  4. M. Mitterberger, W. Horninger, A. Pelzer et al., “A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guided biopsies: impact on prostate cancer detection,” Prostate, vol. 67, no. 14, pp. 1537–1542, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Pallwein, M. Mitterberger, P. Struve et al., “Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection,” European Radiology, vol. 17, no. 9, pp. 2278–2285, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Gosselaar, M. J. Roobol, S. Roemeling, T. Wolters, G. J. L. H. van Leenders, and F. H. Schröder, “The value of an additional hypoechoic lesion-directed biopsy core for detecting prostate cancer,” BJU International, vol. 101, no. 6, pp. 685–690, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. N. B. Delongchamps and G. P. Haas, “Saturation biopsies for prostate cancer: current uses and future prospects,” Nature Reviews Urology, vol. 6, no. 12, pp. 645–652, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. S. Moussa, A. Meshref, L. Schoenfield et al., “Importance of additional “extreme” anterior apical needle biopsies in the initial detection of prostate cancer,” Urology, vol. 75, no. 5, pp. 1034–1039, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Scattoni, A. Zlotta, R. Montironi, C. Schulman, P. Rigatti, and F. Montorsi, “Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature,” European Urology, vol. 52, no. 5, pp. 1309–1322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. I. H. Sung, H. J. Lee, Y. C. Jeong et al., “Should transition zone biopsies be added to 12-core systematic biopsies of the prostate?” Journal of Clinical Ultrasound, vol. 37, no. 5, pp. 281–284, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Dickinson, H. U. Ahmed, C. Allen et al., “Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting,” European Urology, vol. 59, no. 4, pp. 477–494, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Puech, D. Huglo, G. Petyt, L. Lemaitre, and A. Villers, “Imaging of organ-confined prostate cancer: functional ultrasound, MRI and PET/computed tomography,” Current Opinion in Urology, vol. 19, no. 2, pp. 168–176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Kurhanewicz, D. Vigneron, P. Carroll, and F. Coakley, “Multiparametric magnetic resonance imaging in prostate cancer: present and future,” Current Opinion in Urology, vol. 18, no. 1, pp. 71–77, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Haffner, L. Lemaitre, P. Puech et al., “Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection,” BJU International, vol. 108, no. 8, part 2, pp. E171–E178, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Lemaitre, P. Puech, E. Poncelet et al., “Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings,” European Radiology, vol. 19, no. 2, pp. 470–480, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Puech, E. Potiron, L. Lemaitre et al., “Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens,” Urology, vol. 74, no. 5, pp. 1094–1099, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Villers, P. Puech, D. Mouton, X. Leroy, C. Ballereau, and L. Lemaitre, “Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings,” The Journal of Urology, vol. 176, no. 6, pp. 2432–2437, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Shimizu, A. Nishie, T. Ro et al., “Prostate cancer detection: the value of performing an mri before a biopsy,” Acta Radiologica, vol. 50, no. 9, pp. 1080–1088, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. H. U. Ahmed, A. Kirkham, M. Arya et al., “Is it time to consider a role for MRI before prostate biopsy?” Nature Reviews Clinical Oncology, vol. 6, no. 4, pp. 197–206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. R. Engelbrecht, P. Puech, P. Colin, O. Akin, L. Lemaître, and A. Villers, “Multimodality magnetic resonance imaging of prostate cancer,” Journal of Endourology, vol. 24, no. 5, pp. 677–684, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. A. B. Rosenkrantz, F.-M. Deng, S. Kim et al., “Prostate cancer: multiparametric mri for index lesion localization—a multiple-reader study,” The American Journal of Roentgenology, vol. 199, no. 4, pp. 830–837, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. N. B. Delongchamps, M. Peyromaure, A. Schull et al., “Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies,” The Journal of Urology, vol. 189, no. 2, pp. 493–499, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. Bjurlin, X. Meng, J. le Nobin et al., “Optimization of prostate biopsy: the role of MRI targeted biopsy in detection, localization, and risk assessment,” The Journal of Urology, vol. 192, no. 3, pp. 648–658, 2014. View at Publisher · View at Google Scholar
  24. J. S. Wysock, A. B. Rosenkrantz, W. C. Huang et al., “A prospective, blinded comparison of Magnetic Resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial,” European Urology, vol. 66, no. 2, pp. 343–351, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Puech, O. Rouvière, R. Renard-Penna et al., “Prostate cancer diagnosis : multiparametric mr-targeted biopsy with cognitive and transrectal us-mr fusion guidance versus systematic biopsy-prospective multicenter study,” Radiology, vol. 268, no. 2, pp. 461–469, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Roethke, A. G. Anastasiadis, M. Lichy et al., “MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy,” World Journal of Urology, vol. 30, no. 2, pp. 213–218, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. B. K. Park, J. W. Park, S. Y. Park et al., “Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy,” The American Journal of Roentgenology, vol. 197, no. 5, pp. W876–W881, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Sciarra, V. Panebianco, M. Ciccariello et al., “Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy,” Clinical Cancer Research, vol. 16, no. 6, pp. 1875–1883, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Kirby and J. M. Fitzpatrick, “Optimising repeat prostate biopsy decisions and procedures,” BJU International, vol. 109, no. 12, pp. 1750–1754, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. G. A. Sonn, D. J. Margolis, and L. S. Marks, “Target detection: magnetic resonance imaging-ultrasound fusion-guided prostate biopsy,” Urologic Oncology: Seminars and Original Investigations, vol. 32, no. 6, pp. 903–911, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Han, D. Chang, C. Kim et al., “Geometric evaluation of systematic transrectal ultrasound guided prostate biopsy,” The Journal of Urology, vol. 188, no. 6, pp. 2404–2409, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Mazaheri, A. Shukla-Dave, A. Muellner, and H. Hricak, “MR imaging of the prostate in clinical practice,” Magnetic Resonance Materials in Physics, Biology and Medicine, vol. 21, no. 6, pp. 379–392, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Heidenreich, J. Bellmunt, M. Bolla et al., “EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease,” European Urology, vol. 59, no. 1, pp. 61–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Sciarra, V. Panebianco, S. Cattarino et al., “Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy,” BJU International, vol. 110, no. 11, pp. 1661–1665, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. C. M. A. Hoeks, M. G. Schouten, J. G. R. Bomers et al., “Three-tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers,” European Urology, vol. 62, no. 5, pp. 902–909, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. S. H. Lee, M. S. Chung, J. H. Kim, Y. T. Oh, K. H. Rha, and B. H. Chung, “Magnetic resonance imaging targeted biopsy in men with previously negative prostate biopsy results,” Journal of Endourology, vol. 26, no. 7, pp. 787–791, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Vourganti, A. Rastinehad, N. K. Yerram et al., “Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies,” The Journal of Urology, vol. 188, no. 6, pp. 2152–2157, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Lawrentschuk and N. Fleshner, “The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels,” BJU International, vol. 103, no. 6, pp. 730–733, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Lawrentschuk, M. A. Haider, N. Daljeet et al., ““Prostatic evasive anterior tumours”: the role of magnetic resonance imaging,” BJU International, vol. 105, no. 9, pp. 1231–1236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. J. O. Barentsz, J. Richenberg, R. Clements et al., “ESUR prostate MR guidelines 2012,” European Radiology, vol. 22, no. 4, pp. 746–757, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. M. de Rooij, S. Crienen, J. A. Witjes, J. O. Barentsz, M. M. Rovers, and J. P. Grutters, “Cost-effectiveness of Magnetic Resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective,” European Urology, 2013. View at Google Scholar
  42. H. A. Vargas, O. Akin, A. Afaq et al., “Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer,” Journal of Urology, vol. 188, no. 5, pp. 1732–1738, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. G. A. Sonn, S. Natarajan, D. J. A. Margolis et al., “Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device,” The Journal of Urology, vol. 189, no. 1, pp. 86–91, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Marliere, P. Puech, A. Benkirane et al., “The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer,” World Journal of Urology, vol. 32, no. 4, pp. 951–958, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. I. Kaplan, N. E. Oldenburg, P. Meskell, M. Blake, P. Church, and E. J. Holupka, “Real time MRI-ultrasound image guided stereotactic prostate biopsy,” Magnetic Resonance Imaging, vol. 20, no. 3, pp. 295–299, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. A. K. Singh, J. Kruecker, S. Xu et al., “Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy,” BJU International, vol. 101, no. 7, pp. 841–845, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Xu, J. Kruecker, B. Turkbey et al., “Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies,” Computer Aided Surgery, vol. 13, no. 5, pp. 255–264, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. W. Shao, K. V. Ling, R. Wu, C. H. Thng, and W. S. Ng, “Deformable registration between MRI/MRSI and ultrasound images for targeted robotic prostate biopsy,” in Proceedings of the IEEE Conference on Cybernetics and Intelligent Systems, pp. 345–350, December 2004. View at Scopus
  49. A. V. D'Amico, C. M. Tempany, R. Cormack et al., “Transperineal magnetic resonance image guided prostate biopsy,” The Journal of Urology, vol. 164, no. 2, pp. 385–387, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Beyersdorff and B. Hamm, “MRI for troubleshooting detection of prostate cancer,” RöFo, vol. 177, no. 6, pp. 788–795, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. F. Aigner, L. Pallwein, A. Pelzer et al., “Value of magnetic resonance imaging in prostate cancer diagnosis,” World Journal of Urology, vol. 25, no. 4, pp. 351–359, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Villers, P. Puech, X. Leroy, J. Biserte, J.-C. Fantoni, and L. Lemaitre, “Dynamic Contrast-Enhanced MRI for Preoperative Identification of Localised Prostate Cancer,” European Urology Supplements, vol. 6, no. 8, pp. 525–532, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. A. P. Labanaris, K. Engelhard, V. Zugor, R. Nützel, and R. Kühn, “Prostate cancer detection using an extended prostate biopsy schema in combination with additional targeted cores from suspicious images in conventional and functional endorectal magnetic resonance imaging of the prostate,” Prostate Cancer and Prostatic Diseases, vol. 13, no. 1, pp. 65–70, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. C. M. Moore, N. L. Robertson, N. Arsanious et al., “Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review,” European Urology, vol. 63, no. 1, pp. 125–140, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. C. M. Moore, V. Kasivisvanathan, S. Eggener et al., “Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group,” European Urology, vol. 64, no. 4, pp. 544–552, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. M. R. Pokorny, M. de Rooij, E. Duncan et al., “Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies,” European Urology, vol. 66, no. 1, pp. 22–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. V. Mouraviev, S. Verma, B. Kalyanaraman et al., “The feasibility of multiparametric magnetic resonance imaging for targeted biopsy using novel navigation systems to detect early stage prostate cancer: the preliminary experience,” Journal of Endourology, vol. 27, no. 7, pp. 820–825, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Sclaverano, G. Chevreau, L. Vadcard, P. Mozer, and J. Troccaz, “BiopSym: a simulator for enhanced learning of ultrasound-guided prostate biopsy,” in Proceedings of the 17th Annual MMVR Conference—NextMed: Design for/the Well Being ( MMVR17 '09), pp. 301–306, January 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Fiard, S.-Y. Selmi, E. Promayon, L. Vadcard, J.-L. Descotes, and J. Troccaz, “Initial validation of a virtual-reality learning environment for prostate biopsies: realism matters!,” Journal of Endourology, vol. 28, no. 4, pp. 453–458, 2014. View at Publisher · View at Google Scholar · View at Scopus